293 related articles for article (PubMed ID: 33253350)
1. Drug response in association with pharmacogenomics and pharmacomicrobiomics: towards a better personalized medicine.
Hassan R; Allali I; Agamah FE; Elsheikh SSM; Thomford NE; Dandara C; Chimusa ER
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33253350
[TBL] [Abstract][Full Text] [Related]
2. Pharmacomicrobiomics: a novel route towards personalized medicine?
Doestzada M; Vila AV; Zhernakova A; Koonen DPY; Weersma RK; Touw DJ; Kuipers F; Wijmenga C; Fu J
Protein Cell; 2018 May; 9(5):432-445. PubMed ID: 29705929
[TBL] [Abstract][Full Text] [Related]
3. Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?
Sharma A; Buschmann MM; Gilbert JA
Clin Pharmacol Ther; 2019 Aug; 106(2):317-328. PubMed ID: 30937887
[TBL] [Abstract][Full Text] [Related]
4. Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug-microbiome interactions.
Aziz RK; Hegazy SM; Yasser R; Rizkallah MR; ElRakaiby MT
Expert Opin Drug Metab Toxicol; 2018 Oct; 14(10):1043-1055. PubMed ID: 30269615
[TBL] [Abstract][Full Text] [Related]
5. Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery.
Kamath S; Stringer AM; Prestidge CA; Joyce P
Expert Opin Drug Deliv; 2023; 20(10):1315-1331. PubMed ID: 37405390
[TBL] [Abstract][Full Text] [Related]
6. Drug-microbiota interactions: an emerging priority for precision medicine.
Zhao Q; Chen Y; Huang W; Zhou H; Zhang W
Signal Transduct Target Ther; 2023 Oct; 8(1):386. PubMed ID: 37806986
[TBL] [Abstract][Full Text] [Related]
7. Interaction between drugs and the gut microbiome.
Weersma RK; Zhernakova A; Fu J
Gut; 2020 Aug; 69(8):1510-1519. PubMed ID: 32409589
[TBL] [Abstract][Full Text] [Related]
8. Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics.
ElRakaiby M; Dutilh BE; Rizkallah MR; Boleij A; Cole JN; Aziz RK
OMICS; 2014 Jul; 18(7):402-14. PubMed ID: 24785449
[TBL] [Abstract][Full Text] [Related]
9. Pharmacomicrobiomics-Guided Precision Oncology: A New Frontier of P4 (Predictive, Personalized, Preventive, and Participatory) Medicine and Microbiome-Based Therapeutics.
Arga KY; Attia H; Aziz RK
OMICS; 2024 Jan; 28(1):5-7. PubMed ID: 38190279
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacogenomics: the quest for individualized therapy].
López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
[TBL] [Abstract][Full Text] [Related]
11. Pharmacomicrobiomics and type 2 diabetes mellitus: A novel perspective towards possible treatment.
Jia L; Huang S; Sun B; Shang Y; Zhu C
Front Endocrinol (Lausanne); 2023; 14():1149256. PubMed ID: 37033254
[TBL] [Abstract][Full Text] [Related]
12. [Personalized dosing from perspective of pharmacogenomics of drug metabolizing enzymes and transporters].
Zhou Q; Yu LS; Zeng S
Yao Xue Xue Bao; 2017 Jan; 52(1):1-7. PubMed ID: 29911367
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics: Driving Personalized Medicine.
Sadee W; Wang D; Hartmann K; Toland AE
Pharmacol Rev; 2023 Jul; 75(4):789-814. PubMed ID: 36927888
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics and individualized medicine: translating science into practice.
Crews KR; Hicks JK; Pui CH; Relling MV; Evans WE
Clin Pharmacol Ther; 2012 Oct; 92(4):467-75. PubMed ID: 22948889
[TBL] [Abstract][Full Text] [Related]
15. Precision Medicine Goes Microscopic: Engineering the Microbiome to Improve Drug Outcomes.
Lam KN; Alexander M; Turnbaugh PJ
Cell Host Microbe; 2019 Jul; 26(1):22-34. PubMed ID: 31295421
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics: the promise of personalized medicine.
Mancinelli L; Cronin M; Sadée W
AAPS PharmSci; 2000; 2(1):E4. PubMed ID: 11741220
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics for personalized pain medicine.
Ko TM; Wong CS; Wu JY; Chen YT
Acta Anaesthesiol Taiwan; 2016 Mar; 54(1):24-30. PubMed ID: 26976339
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics in Critical Care.
Cheek D; Howington L
AACN Adv Crit Care; 2018; 29(1):36-42. PubMed ID: 29496712
[TBL] [Abstract][Full Text] [Related]
19. Editorial: Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM).
Luo JQ; Shu Y; Zhang W
Front Endocrinol (Lausanne); 2023; 14():1287807. PubMed ID: 37795358
[No Abstract] [Full Text] [Related]
20. Integration of pharmacogenomics and theranostics with nanotechnology as quality by design (QbD) approach for formulation development of novel dosage forms for effective drug therapy.
Jhawat V; Gulia M; Gupta S; Maddiboyina B; Dutt R
J Control Release; 2020 Nov; 327():500-511. PubMed ID: 32858073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
